產品分類

    Products

    產品中心/ PRODUCTS

    我的位置:首頁  >  產品中心  >    >  動物活體成像設備  >  腫瘤測量儀

    腫瘤測量儀

    • 更新時間:2024-10-11
    • 訪  問  量:891

    簡要描述:動物腫瘤測量儀,非常適合對大鼠小鼠等動物的皮下腫瘤進行快速測量、分析,精確測量動物腫瘤并對腫瘤信息存檔與跟蹤

    在線咨詢

    聯系電話:021-54377179

    產品詳情

    動物腫瘤測量儀,非常適合對大鼠小鼠等動物的皮下腫瘤進行快速測量、分析,精確測量動物腫瘤并對腫瘤信息存檔與跟蹤。


    主要技術參數: 

    · 測量范圍:0-25mm腫瘤尺寸:20*20*20mm
    · 3D測量精確度:<0.3mm
    · 圖像捕捉時間:0.1s
    · 接口:USB 2.0
    · 相機:1600*1200 像素(2MP)
    · 工作距離:50mm


    動物腫瘤測量分析儀的主要特點: 
    · 手持式成像裝置,實現立體成像;
    · 適合測量不同尺寸的腫瘤;
    · 方便使用:觸屏式電腦,操作方便;
    · 內置軟件,自動計算腫瘤尺寸,跟蹤整個實驗進展。 
      

    · 快速,高效,保證了高通量和可靠測量;
    · 全自動測量跟蹤系統;
    · 實時數據分析與處理。 


         
      
     


    部分用戶: 

    Hunter College, CUNY

    Vanderbilt University Medical Center

    Hainan Medical University

    Howard Hughes Medical Institute

    Memorial Sloan Kettering Cancer Center

    Cancer Center Amsterdam

    GlaxoSmithKline

    Imec

    K.U.Leuven

    Neuro-Electronics Research Flanders

    Pepric

    PharmaVize

    reMYND

    University Ghent

    SEPS Pharma

    Vlaams Instituut voor Biotechnologie

    University Antwerp

    ThromboGenics

    Janssen Pharmaceutica

    City University of Hong Kong


    參考文獻:

    1.Adams EJ, Karthaus WR, Hoover E, et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2019;571(7765):408-412. doi:10.1038/s41586-019-1318-9.
    2.Zhang Z, Zhou C, Li X, et al. Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation. Cancer Cell. 2020;37(4):584-598.e11. doi:10.1016/j.ccell.2020.03.001.
    3.Santich BH, Park JA, Tran H, et al. Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies. Sci Transl Med. 2020;12(534):eaax1315. doi:10.1126/scitranslmed.aax1315.
    4.Park JA, Xu H, Cheung, I, et al. Abstract B38: Tetravalent bispecific antibodies specific for HER2 and disialoganglioside GD2 to engage polyclonal T cells for osteosarcoma therapy. Cancer Res. 2018;78(19),B38.doi:10.1158/1538-7445.PEDCA17-B38.
    5.Wu CF, Wu CY, Lin CF, et al. The anticancer effects of cyanidin 3-O-glucoside combined with 5-fluorouracil on lung large-cell carcinoma in nude mice. Biomed Pharmacother. 2022;151:113128. doi:10.1016/j.biopha.2022.113128.
    6.Wang L, Hoseini SS, Xu H, et al. Silencing Fc Domains in T cell-Engaging Bispecific Antibodies Improves T-cell Trafficking and Antitumor Potency. Cancer Immunol Res. 2019;7(12):2013-2024. doi:10.1158/2326-6066.CIR-19-0121.
    7.Grochowska A, Statkiewicz M, Kulecka M, et al. Evidence supporting the oncogenic role of BAZ1B in colorectal cancer. Am J Cancer Res. 2022;12(10):4751-4763. 
    8.Hoseini SS, Vadlamudi M, Espinosa-Cotton M, et al. T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia. J Immunother Cancer. 2021;9(5):e002509. doi:10.1136/jitc-2021-002509.
    9.Beguin E, Gray MD, Logan KA, et al. Magnetic microbubble mediated chemo-sonodynamic therapy using a combined magnetic-acoustic device. J Control Release. 2020;317:23-33. doi:10.1016/j.jconrel.2019.11.013.
    10.Mao N, Gao D, Hu W, et al. Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes. Mol Cancer Ther. 2019;18(9):1577-1586. doi:10.1158/1535-7163.MCT-18-1386.
    11.Wu Z, Guo HF, Xu H, et al. Development of a Tetravalent Anti-GPA33/Anti-CD3 Bispecific Antibody for Colorectal Cancers. Mol Cancer Ther. 2018;17(10):2164-2175. doi:10.1158/1535-7163.MCT-18-0026.
    12.Poty S, Mandleywala K, O'Neill E, et al. 89Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma. Theranostics. 2020;10(13):5802-5814. doi:10.7150/thno.44772.
    13.Hoseini SS, Guo H, Wu Z, et al. A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia. Blood Adv. 2018;2(11):1250-1258. doi:10.1182/bloodadvances.2017014373.
    14.Zhang Z, Karthaus WR, Lee YS, et al. Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer. Cancer Cell. 2020;38(2):279-296.e9. doi:10.1016/j.ccell.2020.06.005.
    15.Poty S, Carter LM, Mandleywala K, et al. Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2019;25(2):868-880. doi:10.1158/1078-0432.CCR-18-1650.




        

        

        :,

             

        :

        yuyanbio

        :yuyanbio

        

    在線咨詢

    留言框

    • 產品:

    • 您的單位:

    • 您的姓名:

    • 聯系電話:

    • 常用郵箱:

    • 省份:

    • 詳細地址:

    • 補充說明:

    • 驗證碼:

      請輸入計算結果(填寫阿拉伯數字),如:三加四=7
    上海玉研科學儀器有限公司
    地址:上海市閔行區興梅路485號眾欣大廈506室
    郵箱:sales@yuyanbio.com
    傳真:021-35183767
    掃一掃關注我們
    SCAN
    2022精品天堂在线视频| 精品久久人人爽天天玩人人妻| 精品人妻一区二区三区毛片| 日韩精品视频在线观看免费| 日本亚欧乱色视频在线观看| 99re6这里有精品热视频| 99热都是精品久久久久久| 亚洲精品第一国产综合境外资源 | 精品人妻少妇一区二区三区在线| 亚洲精品亚洲人成在线观看下载| 欧美性videos高清精品| 99精品国产一区二区| 日本在线观看一级高清片| 国产精品1区2区| 午夜精品久久久内射近拍高清| 精品偷自拍另类在线观看| 国产精品综合久成人| 日韩一区精品视频一区二区| 国产高清在线精品一本大道国产| 黄+色+性+人免费| 欧美日韩精品一区二区在线播放| 亚洲国产av无码精品| 国产精品久久久久久福利漫画| 久久丝袜精品中文字幕| 精品人伦一区二区三区潘金莲| 国产精品黄页免费高清在线观看| 在线精品亚洲一区二区小说| 中文字幕精品视频| 国产一区二区免费不卡在线播放| 久久精品成人免费看| 亚洲精品视频在线看| 国产精品亚洲精品| 日韩免费不卡视频| 国产精品人成在线观看| 人妻精品久久久久中文字幕一冢本| 国产精品二区观看| 国产久热精品无码激情| 亚洲国产精品一区二区九九| 日本精品卡一卡2卡3卡四卡| 无码人妻精品一区二区三区久久久 | 国产精品毛片一区二区|